We have performed thermal (differential scanning calorimetry) and rheological studies in the preformulation phase of ethosuximide suppositories to determine the influence of the active ingredient and adjuvants on the melting characteristics and rheological performance of the suppositories. Both types of studies were performed on the fatty bases witepsol H-19 and suppocire AP, each mixed with 5% w / w polysorbate 80, 0.1% w / w docusate sodium and 3% w / w tetranyl AT-1 / DP and on the suppository formulations obtained by the addition of 150 mg of ethosuximide to these excipients. Pure lipophilic excipients have two peaks in the DSC curve. The first one occurs at lower temperatures (27.35 8C for the suppocire AP and 34.3 8C for the witepsol H19) and the second peak at higher temperatures (36.27 and 35.95 8C for the suppocire AP and witepsol H19, respectively). Polysorbate 80, docusate sodium and tetranyl AT-1 / DP cause the first melting peak to disappear and the second peak to occur at a lower temperature. The thermograms of the formulas show two melting peaks and the endothermic peak does not appear due to the melting of ethosuximide (47.8 8C). We attribute this behavior to the solubility of the drug in the melted excipient, thus originating a decrease of the melting temperature of the second peak in the DSC scan. The excipients and formulations behave as Newtonian fluids and the influence of ethosuximide and adjuvants can be noted in an increase in the viscosity of the suppository mass.  2003 Elsevier Science B.V. All rights reserved.
. Introduction
The drugs and adjuvants (surfactants, polymers, and waxes, among others) used to improve the release and The fatty bases of suppositories (also termed semiabsorption characteristics of the drug can form eutectic synthetic glycerides) are complex mixtures of triglycerides mixtures, solid solutions or complexes with the lipophilic that present three different crystalline changes and a glassy excipients, modifying the melting behavior of the drug and state. Two of the crystalline forms (a and b) are metathe rheological properties of the suppository mass, thus stable, transforming during storage into the stable form affecting the bioavailability of the drug in these dosage (b9) and thus modifying the melting characteristics of forms (Margarit et al., 1991; Chien, 1995;  Casahoursat et these excipients (Ford and Timmins, 1989) . The release of al., 1978) . drugs in suppositories manufactured with lipophilic excipiDifferential scanning calorimetry is a thermal method ents takes place upon the melting of the suppository in the used in preformulation studies (Giron et al., 1985 ; Giorrectal ampulla and the subsequent spread of the mass to dano et al., 1990; Dash et al., 1999) stability (Pryce-Jones cover the mucous membrane. The spreadability of a et al. , 1987 , 1992 Coben and Lordi, 1980) and quality suppository depends on the viscosity of the suppository control of suppositories (Bucci et al., 2000) . Nonetheless, mass at body temperature and therefore on the rectal studies on the rheological behavior of the suppository mass water / excipient exposure surface, as well as on the are rare in the literature on suppositories despite the fact sedimentation or diffusion of the drug in the excipient / that their viscosity can affect the release and absorption ofr ectal mucosa interface (Casahoursat, 1988; Moes, 1980;  the drug (Moes, 1974; Dal Zoto et al., 1991; Yahagi et al., Guillot and Lombard, 1973; Rutten-Kingman et al., 1979 . Therefore, this study on the preformulation phase of ethosuximide suppositories aimed to use differential scan- and 3% w / w of tetranyl AT-1 / DP (Ty) and on the Corporation S.A., Barcelona).
suppository formulations given in Table 1 , obtained by the addition of 150 mg of ethosuximide to the previously mentioned excipients. The assay was performed in trip-2 .2. Suppository preparation licate, weighing out 760.5 mg of sample, placing it in an aluminum capsule and subjecting it to thermal treatment The composition of the formulations of the suppositories applying a heating rate of 1 8C / min in the temperature studied in this work are summarized in Table 1 . The range of 25-70 8C. Before the assays, the excipients and amounts of suppocire AP and witepsol H-19 shown in this suppositories were kept at room temperature for 24 h. table have been determined using the replacement factor
The melting point of the samples was taken as the given in Table 2. temperature at the melting peak in the DSC curve. To prepare the suppositories, the excipient was melted at a temperature of 4060.5 8C and then ethosuximide was 2 .4. Rheological study added (formulations A and E). When a surfactant was added, it was done before the addition of the ethosuximide.
The rheological study was performed on the excipients All the formulations were prepared with gentle stirring and formulations mentioned in the previous section. The until obtaining a homogenous mixture (appearance of a rheological measurements were performed on three suptransparent liquid). They were then poured into the metalpositories (approx. 5 g mass) and on an equivalent weight lic suppository mold comprising 126 receptacles (suppositof excipient. The samples were melted at a temperature of ory weight 1.5 g) and cooled at room temperature. The 3960.2 8C and then placed in the small sample adapter of solidified suppositories are kept refrigerated (4 8C) away the viscosimeter (Brookfield LVT, Brookfield Engineering from light. Laboratories, MA), which was previously heated to the DSC scans of the S-AP and W-H19 excipients and of the mixtures of these excipients with the surfactants utilized are shown in Fig. 2 . The width of the peak is due 3 . Results and discussion to the complex composition of the excipients; they are formed of mixtures of mono-, di-and triglycerides in The phase diagram based on the melting temperature of addition to incorporating special additives such as polythe ethosuximide / lipophilic excipient (S-AP and W-H19) oxyethylene compounds in the case of S-AP and glyceryl mixtures are shown in Fig. 1 . It can be seen that the drug ricinoleate in the case of W-H19 (Kibbe, 2000) . The decreases the melting temperature of the lipophilic excipisurfactants added to S-AP and W-H19 cause the first ents by approximately 4 8C. However, an increase in the melting peak to disappear and produce the fall of second drug concentration in the samples does not produce peak of melting temperature 3.18, 3.87 and 3.37 8C when significant variations in the melting temperature of the the adjuvant is Ps, Ds and Ty, respectively. This effect is suppository excipients. In contrast, with a drug concenless pronounced when W-H19 is the excipient, since the tration of under 30% for W-H19 and 40% for S-AP, the fall in the melting temperature is less, being 2.12, 2.47 and only melting peak observed corresponds to the suppository 3.24 8C for the same surfactants (Ps, Ds and Ty). excipient. When the amount of drug in the sample is 30
This behavior could be due to the fact that the adjuvant and 40% for W-H19 and S-AP, respectively, the DSC substances are surfactants and have distinct natures: liquid curve presents the endotherm corresponding to the excipilike polysorbate 80, semisolid in the case of tetranyl ent and a slight change in the baseline at a higher temperature. However, the endotherm corresponding to the drug cannot be clearly discerned. The thermogram of the mixtures with a drug concentration of over 30% and 40% presents two endotherms corresponding to the excipient (low temperature) and to the drug (high temperature). The endotherm of the ethosuximide is wider than the endotherm for the active ingredient alone and its temperature rises when the drug concentration of the samples increases. The disappearance (low concentration) and widening (high concentration) of the ethosuximide endotherm peak is most likely due to the intermixing of the two components (eutectic formation).
The phase diagram is of a monotectic system (Kaur et al., 1980) , but it has the form of an eutectic diagram in AT-1 / DP and a solid plastic like docusate sodium. These ethosuximide changes the melting behavior of the excipiadjuvants are miscible in the lipophilic excipient, then, ents studied, producing a wider DSC curve with two homogeneous aspect and heterogeneous composition mixmelting peaks. ture were obtained. Consequently, the melting temperature
Comparing the thermal behavior of the formulas with of the base excipient decreased.
that of the base excipients, it can be noted that the first The ANOVA analysis applied to the melting temperature melting peak of formulas A, B, C, E, F and G occurs at of the suppository excipients has revealed statistically 27-28 8C, with the second peak located between 33 and significant differences (P,0.05) between the excipients 34 8C. The melting temperature of the second peak drops with S-AP and those with W-H19. Multiple comparison 2.5 8C in the case of formula A and 2.14 8C for formula E. least significant difference (LSD) test was applied to the The changes with formulas B, C, F and G are not average values of the melting temperatures. The results significant. The first melting peak disappears in formulas D indicate that, with the S-AP excipient, the differences and H. The temperature melting peak of the wider DSC found occur between the lipophilic base and the excipient curve decreases by 1.55 8C in formula E and remains group containing surfactants (S-AP1Ps, S-AP1Ds, Sunchanged in formula H. AP1Ty). Therefore, the Ps, Ds and Ty show a similar
In the DSC scans of the formulas (Fig. 3) , the endoeffect in decreasing the melting temperature of the S-AP. therm corresponding to the melting of the ethosuximide is Witepsol H-19 reveals differences among the lipophilic absent. This circumstance is due to the fact that, in a base itself, the excipients containing Ps and Ds, and the melted state, the formulation components are completely excipient with Ty. The Ps and Ds surfactants behave miscible. However, recrystallization of ethosuximide was similarly, whereas the Ty decreases the melting temperaobserved when the mass solidifies at room temperature and ture to a greater extent.
during the sample conservation. Therefore, we suggest that The DSC scans for ethosuximide and the six formulaboth components at room temperature are in the form of a tions are shown in Fig. 3 . The ethosuximide has a wellsolid and separate, suggesting the absence of a chemical defined endothermic peak, with a melting point of 47.8 8C interaction between these components. and a heat of fusion of 131 J / g. The incorporation of ANOVA analysis has been applied to the temperature of the second endotherm of both groups of formulas. The results indicate that there are statistically significant differences (P,0.05) among the formulas of each group. These differences lie between formulas A-C and formula D and between formulas E and F and formulas G and H.
The rheological study revealed that the different excipients and formulations behave as Newtonian fluids, since 21 the rheograms representing the shear rate (s ) versus the shear stress (Pa) showed a linear relationship between the two parameters. Fig. 4 is presented as a model of that were in a liquid state.
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